Literature DB >> 8594332

Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance.

S L Chiang1, R K Taylor, M Koomey, J J Mekalanos.   

Abstract

The toxin-coregulated pilus (TCP) of Vibrio cholerae O1 is required for successful infection of the host. TcpA, the structural subunit of TCP, belongs to the type IV family of pilins, which includes the PilE pilin of Neisseria gonorrhoeae. Recently, single amino acid changes in the N-terminus of PilE were found to abolish autoagglutination in gonococci. As type IV pilins demonstrate some similarities in function and amino acid sequence, site-directed mutagenesis and allelic exchanges were used to create corresponding mutations in TcpA. All four mutant strains demonstrated autoagglutination defects, and all were highly defective for colonization in the infant mouse model. These results support the previously proposed correlation between autoagglutination and colonization. Finally, all four mutants are serum sensitive, indicating that TcpA plays a role in serum resistance, a phenotype previously attributed to TcpC. As the mutations have similar effects in N. gonorrhoeae and V. cholerae, our results support the idea that type IV pilins have similar functions in a variety of pathogenic bacteria.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594332     DOI: 10.1111/j.1365-2958.1995.mmi_17061133.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  53 in total

1.  Construction of a Vibrio cholerae vaccine candidate using transposon delivery and FLP recombinase-mediated excision.

Authors:  S L Chiang; J J Mekalanos
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 2.  Type II secretion and pathogenesis.

Authors:  M Sandkvist
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Mechanism of ToxT-dependent transcriptional activation at the Vibrio cholerae tcpA promoter.

Authors:  Robin R Hulbert; Ronald K Taylor
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

4.  Molecular characterization of a new variant of toxin-coregulated pilus protein (TcpA) in a toxigenic non-O1/Non-O139 strain of Vibrio cholerae.

Authors:  B Nandi; R K Nandy; A C Vicente; A C Ghose
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Identification of diverse archaeal proteins with class III signal peptides cleaved by distinct archaeal prepilin peptidases.

Authors:  Zalán Szabó; Adriana Oliveira Stahl; Sonja-V Albers; Jessica C Kissinger; Arnold J M Driessen; Mechthild Pohlschröder
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

6.  A Serratia marcescens OxyR homolog mediates surface attachment and biofilm formation.

Authors:  Robert M Q Shanks; Nicholas A Stella; Eric J Kalivoda; Megan R Doe; Dawn M O'Dee; Kira L Lathrop; Feng Li Guo; Gerard J Nau
Journal:  J Bacteriol       Date:  2007-08-03       Impact factor: 3.490

7.  The type 4 pili of enterohemorrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes.

Authors:  Juan Xicohtencatl-Cortes; Valério Monteiro-Neto; Zeus Saldaña; Maria A Ledesma; Jose Luís Puente; Jorge A Girón
Journal:  J Bacteriol       Date:  2008-10-24       Impact factor: 3.490

8.  Integration host factor positively regulates virulence gene expression in Vibrio cholerae.

Authors:  Emily Stonehouse; Gabriela Kovacikova; Ronald K Taylor; Karen Skorupski
Journal:  J Bacteriol       Date:  2008-05-02       Impact factor: 3.490

9.  Modulation of expression of the ToxR regulon in Vibrio cholerae by a member of the two-component family of response regulators.

Authors:  S M Wong; P A Carroll; L G Rahme; F M Ausubel; S B Calderwood
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  The alternative sigma factor sigma(E) plays an important role in intestinal survival and virulence in Vibrio cholerae.

Authors:  Gabriela Kovacikova; Karen Skorupski
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.